胃癌患者血清Ⅳ型胶原含量变化及其临床意义

目的:观察胃癌患者血清Ⅳ型胶原(ColⅣ)含量变化及其与肿瘤浸润及转移的关系.方法:应用放射免疫方法测定20例胃癌患者血清ColⅣ含量,并探讨其与胃癌TNM分期、淋巴结转移的关系.结果:肿瘤组血清ColⅣ含量明显高于对照组(P<0.01);TNM分期中,Ⅱ,Ⅳ期组血清ColⅣ含量显著高于Ⅰ期组(P<0.05);淋巴结转移组显著高于无淋巴结转移组(P<0.01).结论:胃癌患者血清ColⅣ含量变化与肿瘤的浸润及转移等生物学行为密切相关,观察血清ColⅣ含量及其变化,对胃癌患者的病情及预后判断有一定的参考价值.     

食管癌患者血清一氧化氮含量变化及其临床意义

目的：观察食管癌患者血血 氧化氮（ＮＯ）含量变化及其与肿瘤恶性程度的关系。方法：应用改进的Ｇｒｉｅｓｓ法测定２８例食管癌患者血清ＮＯ含量,并探讨其与食管癌的病理分级、淋巴结转移的关系。结果：食管癌患者血清ＮＯ含量明显高于对照组（Ｐ〈０．０１）;病理分级中,ⅡⅢ级组血清ＮＯ含量显著高于Ⅰ级组（Ｐ〈０．０１）,Ⅲ级组血清ＮＯ含量显著高于Ⅱ级组（Ｐ〈０．０５）;血清ＮＯ含量变化与淋巴结转移无关。结论：测     

乳腺癌患者血清血管内皮细胞生长因子的检测及其临床意义

目的 :研究乳腺癌血清血管内皮生长因子 ( Vascular endothelial growthfactor,VEGF)的表达水平及其和微血管计数 ( MVC)、临床病理特征之间的关系。方法 :免疫组化 SP法测定微血管计数 ,酶联免疫吸附法测定血清 VEGF表达水平 ,结合临床病理特征进行分析。结果 :乳腺癌患者血清 VEGF中位数为 393.5 pg/ml,健康人 66.0 0 pg/ml。乳腺癌患者血清 VEGF高于健康人 ,差异具有显著性 ( P<0 .0 1 )。血清 VEGF临床分期 、 期高于 期 ,差异具有显著性 ( P<0 .0 1 )。 、 期之间无显著性差异 ( P>0 .0 5 )。临床分级 、 级高于 级 ,差异具有显著性 ( P<0 .0 1 ) , 、 级之间无显著性差异 ( P>0 .0 5 )。腋窝淋巴结转移者高于未转移者 ,差异具有显著性 ( P<0 .0 1 )。高 MVC组患者血清 VEGF阳性率明显高于低 MVC组 ,差异具有显著性 ( P<0 .0 5 )。结论 :血清 VEGF表达与乳腺癌的进展、恶性程度、腋窝淋巴结转移相关 ,可作为判断乳腺癌恶性程度和淋巴结转移的一个生物学指标     

胃癌患者血清及组织中组织蛋白酶-D、谷胱甘肽-S-转移酶活性测定的临床意义

目的　探讨组织蛋白酶 - D(Cath- D)、谷胱甘肽 - S-转移酶 (GST)活性变化与胃癌发生、发展及预后的关系。　方法　检测胃癌、单纯性胃炎、胃炎伴癌前病变患者血清、癌组织、癌旁组织、胃窦粘膜中 Cath- D、GST的活性和手术前后血清 GST活性。　结果　 (1)胃癌组的 Cath- D、GST的活性显著高于单纯性胃炎组及胃炎伴癌前病变组 (P<0 .0 1) ,胃炎伴癌前病变组 GST的活性显著高于单纯性胃炎组 (P<0 .0 5 ) ,Cath- D活性与单纯性胃炎组比较差异无显著性 (P>0 .0 5 )。 (2 )胃癌组织 Cath- D、GST的活性显著高于癌旁组织 (P<0 .0 5 )、癌旁组织中Cath- D、GST的活性显著高于对照组织 (P<0 .0 5 )。 (3)伴有淋巴结转移的胃癌组织中 Cath- D活性显著高于不伴有淋巴结转移的 (P<0 .0 5 ) ,GST的活性在伴有与不伴有淋巴结转移者中差异无显著性 (P>0 .0 5 )。 (4) Cath- D的活性与按预后好坏的组织学分型 (P<0 .0 1)、按 TNM的分期 (P<0 .0 1)等病理指标有密切相关 ,而 GST的活性与病理指标无显著相关 (P>0 .0 5 )。 (5 )胃癌手术后 10天血清中 GST的活性明显低于手术前 (P<0 .0 1)。　结论　Cath- D、GST活性联合检测可用于胃癌高危人群筛选、监测癌前病变进展及预测肿瘤复发     

血清CA242 CA50和LN水平与大肠癌转移及病理分期的关系

目的　探讨 CA2 42 ,CA5 0和层粘连蛋白 (L N )水平与大肠癌转移及病理分期的关系 .方法　采用放射免疫分析法 .结果　 38例大肠癌患者术前 CA2 42 ,CA5 0和 L N血清含量明显高于术后 (P<0 .0 1,P<0 .0 5和 P<0 .0 5 ) ;2 7例有淋巴结转移者 CA2 42 ,CA5 0及 L N血清含量明显高于 11例无淋巴结转移者 (P<0 .0 1,P<0 .0 5和 P<0 .0 5 ) ;Dukes病理分期中 ,CA2 42血清含量 期组 (16例 )高于 期组 (11例 ) , 期组高于 + 期组 (11例 ) ,差异均非常显著 (P<0 .0 1) ;CA5 0血清含量 , 期组和 期组均明显高于 + 期组 (P<0 .0 1) ;L N血清含量 , 期组高于 + 期组 (P<0 .0 5 ) .结论　 CA2 42 ,CA5 0含量与大肠癌的病理分期和转移密切相关 ,对病情监测及预后有一定的临床价值     

胃癌患者血清型胶原、层粘连蛋白含量的测定及其临床意义

目的　测定胃癌患者血清 型胶原 ( Col )、层粘连蛋白 ( L N )含量 ,并探讨其临床意义。方法　应用放射免疫法测定 32例胃癌患者血清 Col 、L N含量。结果　胃癌患者血清 Col 与 L N含量均明显高于正常人 ( P<0 .0 5 ) ,有淋巴结转移的胃癌患者血清 Col 与 L N含量均明显高于无淋巴结转移的胃癌患者 ( P<0 .0 5 )。结论　胃癌患者血清 Col 、L N含量变化与癌细胞浸润、转移等生物学行为有关 ,监测血清 Col 、L N水平及其变化 ,对胃癌患者的病情及预后判断有一定的参考价值     

检测胃癌患者血清中血管内皮生长因子和一氧化氮水平的临床意义

目的 :通过检测胃癌患者术前血清中血管内皮生长因子 (VEGF)和一氧化氮 (NO)水平 ,探讨VEGF和NO与胃癌的关系及其临床意义。方法 :分别采用酶联免疫吸附测定 (ELISA)法和分光光度法检测 72例胃癌、5 5例慢性胃炎患者和 30例健康人血清中VEGF和NO的含量。结果 :慢性胃炎患者血清中VEGF和NO含量与健康人比较 ,差异均无显著性 (P >0 .0 5 ) ;而胃癌患者血清VEGF和NO含量较慢性胃炎患者和健康人明显增高 (P <0 .0 1) ,且随着胃癌浸润深度增加、有淋巴结转移以及TNM分期愈晚者而显著增高 (P <0 .0 1或 0 .0 5 )。同时血清VEGF与NO含量呈明显正相关 (r =0 .82 4 ,P <0 .0 1)。结论 :VEGF和NO与胃癌的发生发展密切相关 ,术前检测血清VEGF和NO含量可作为判断胃癌浸润转移以及TNM分期的有效生物学指标     

悬浮芯片检测血清HIF-1α的含量对于乳腺癌诊断的价值

目的:探讨乳腺浸润性导管癌患者组织和血清中缺氧诱导因子-1α(HIF-1α)的表达水平及其与乳腺癌临床病理特征的关系。 方法: 采用悬浮芯片技术（suspension array）检测31例健康人、20乳腺良性肿瘤患者、117例乳腺原发浸润导管癌患者及10例乳腺复发浸润导管癌患者血清和组织中HIF-1α蛋白的表达水平,分析其与乳腺癌临床病理特征的关系。 结果:(1)原发、复发浸润性导管癌组血清和组织中HIF-1α含量高于良性肿瘤组和正常对照组 (P<0.01);(2)复发浸润导管癌组血清和组织中HIF-1α含量明显高于原发浸润导管癌(P<0.01和P<0.05);(3)良性肿瘤组和正常对照组血清和组织中HIF-1α含量之间没有统计学意义;(4)血清和组织中 HIF-1α的水平与乳腺浸润性导管癌患者临床分期、病理组织学分级、肿瘤大小、淋巴结转移等密切相关(P < 0.01)。血清和组织中HIF-1α的含量变化呈正相关(P <0.01).结论: 乳腺浸润性导管癌血清HIF-1α含量的异常变化可能是癌变过程的进展行为,而血清HIF-1α的水平可能成为评价乳腺浸润性导管癌临床分期、病理组织学分级、肿瘤大小、淋巴结转移等生物学的重要指标。     

C-反应蛋白与胃癌临床病理及预后的关系

目的:检测胃癌患者术前术后血清C-反应蛋白(CRP)水平,探讨C-RP与不同病理组织类型及分化程度的胃癌患者手术预后的关系.方法:采用免疫比浊度法测定病理证实为胃癌患者192例的血清CRP含量.结果:血清CRP的阳性表达与病理类型显著相关,术前血清CRP阳性胃癌高于阴性胃癌(P<0.01);血清CRP阳性表达与胃癌分化程度有关,分化程度越高CRP阳性表达越高;胃癌淋巴结转移组血清CRP阳性表达高于无转移组(P<0.05);进一步病例随访追踪表明:术前血清CRP水平阳性者死亡率较阴性者高,术后血清CRP升高者死亡率较不升高者高.结论:血清CRP水平与肿瘤的发展和恶化程度与肿瘤的复发和转移有关.因此,血清CRP阳性与否是胃癌的又一个生物学特性.     

血管内皮生长因子-C在卵巢上皮癌血清中的表达及其与侵袭和淋巴结转移的关系

目的观察血管内皮生长因子-C(VEGF-C)在卵巢上皮癌患者血清中的表达及其与侵袭、淋巴结转移的关系。方法 52例卵巢上皮癌患者,根据术后病理分为伴淋巴结转移亚组29例,不伴淋巴结转移亚组23例;另选择卵巢囊肿手术患者11例采用酶联免疫吸附技术(ELISA法)检测上述患者血清中VEGF-C的水平,并探讨其与卵巢上皮癌的侵袭及淋巴道转移的关系。结果卵巢上皮癌组清中VEGF-C的水平明显高于卵巢囊肿组(P<0.05)。卵巢上皮癌Ⅲ～Ⅳ期患者血清VEGF-C水平明显高于Ⅰ～Ⅱ期(P<0.05);Ⅲ级亚组明显高于Ⅰ～Ⅱ级亚组(P<0.05);伴淋巴结转移亚组血清VEGF-C水平明显高于不伴淋巴结转移亚组(P<0.05)结论血清VEGF-C水平与卵巢上皮癌的侵袭程度及病理分级高低、淋巴结有无转移显著相关。     

APPLICATION OF LORNOXICAM TO PATIENT-CONTROLLED ANALGESIA IN PATIENTS UNDERGOING ABDOMINAL SURGERIES

FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…     

Dr.Zhang Ren''''s Experience in the Acupuncture Treatment of Different Diseases with the Same Therapeutic Principle

Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.     

Luo Lingjie''''s Experience in Treating Chronic Nephropathy

In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.     

Acupuncture Combined with Spinal Tui Na for Treatment of Primary Dysmenorrhea in 30 Cases

Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.     

猪肺磷脂注射液联合经鼻持续气道正压通气对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性的影响

目的 探讨猪肺磷脂注射液联合经鼻持续气道正压通气(NCPAP)对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性(CK-MB)的影响.方法 选取呼吸衰竭早产儿80例,分为观察组和对照组各40例.对照组采用NCPAP给氧治疗,观察组给予NCPAP给氧联合猪肺磷脂气管内给药.观察两组患儿治疗前及治疗12h、24 h后PaO2、PaCO2、血氧饱和度(SaO2)、pH的变化情况,检测治疗前及治疗5d后血清CK-MB水平;评估两组患儿的临床治疗效果.结果 两组患儿PaO2、PaCO2、SaO2、pH比较,差异均有统计学意义(P＜0.05),其中观察组治疗后的PaO2、SaO2、pH均高于对照组,PaCO2则低于对照组.两组的PaO2、SaO2、pH均随观察时间延长而升高(P＜0.05),PaCO2均随观察时间的延长而降低(P＜0.05).观察组治疗有效率为87.5％,显著高于对照组的70.0％ (P ＜0.05).治疗5d后两组患儿血清CK-MB水平均较前降低(P＜0.05),且观察组明显低于对照组(P＜0.05).结论 猪肺磷脂注射液气管内给药联合NCPAP可以显著降低呼吸衰竭早产儿CK-MB的含量,提高治疗有效率,起到很好的呼吸循环支持作用.     

Acupuncture Treatment of Vomiting

CASE HISTORY A female patient, 46 years old, head of the foreign affairs department of a certain university in Beijing, paid her first visit on October 9, 2006, with the chief complaint of vomiting for one month. She got vomiting after meals in early September. Before that, she had discomfortable sensation in the stomach due to angry with others, but she didn't pay much attention. Later, it developed into vomiting after eating. After the vomiting, the discomfort would be relieved, but with slight hypodynamia. She was once diagnosed as having 'neurogenic vomiting'. Having taken some western and Chinese drugs, the above symptoms were a little bit improved, but she would have nausea upon eating and with regurgitation. Because of the fear for vomiting, she did not dare to have food intake, with body weight reduction of 6 kilos in one month.     

Qiu Baoguo''''s Experience in Treating Consumptive Syndromes after Radio-Chemotherapies

Radiotherapy and chemotherapy are the important modern medical therapies for malignant tumors,yet they can also bring about serious local and systemic toxic side reactions so to decrease the patient;'s life quality,manifested by a series of consumptive symptoms.Having engaged in the combined work of Chinese and western medicine for nearly 50 years,the research fellow Qiu Baoguo in Henan Provincial Academy of TCM has developed his unique views on the TCM study of consumptive syndromes.The author of this essay had once the fortune tO follow Dr.Qiu in clinic,and specially would like to introduce in the following Dr.Qiu's experience in treating consumptive syndromes after radio-chemotherapies for patients with malignant tumor.     

Insomnia Due to Deficiency of Both the Heart and Spleen Treated by Acupuncture-Moxibustion and Chinese Tuina

OBJECTIVE: To observe therapeutic effects of the comprehensive therapy of acupuncture-moxibustion and Chinese Tuina for treatment of insomnia due to deficiency of both the heart and spleen. METHODS: 92 cases were divided randomly into the treatment group (treated by acupuncture-moxibustion and Chinese Tuina) and the control group (treated by acupuncture-moxibustion). RESULTS: The therapeutic effect of the treatment group was obviously superior to that of the control group (the CHI2 test showed P < 0.01). CONCLUSIONS: The comprehensive therapy of acupuncture-moxibustion and Chinese Tuina can give marked therapeutic effects for treatment of insomnia due to deficiency of both the heart and spleen.     

Survey and practice of reporting quality of randomized controlled clinical trials on traditional Chinese medicine

Evidence obtained from randomized controlled trials （RCTs） has been generally accepted as the gold standard in the evaluation of clinical effectiveness. Readers need to understand the trial design, implementation, results, analysis and interpretation, so as to fully Jnderstand the results of RCTs. Thus, the investigators of RCTs have to report these items in a complete, accurate and clear manner. Since 1998, we have conducted several evaluations on the reporting quality of RCTs published in Chinese journals on traditional Chinese medicine （TCM） and results have shown that there is an urgent need for higher quality RCTs on TCM.